Changes in the diagnostic documentation of the Austrian LKF 2020 model

18

May 2020

The document “Changes and innovations in the 2020 models” provides the most significant changes and innovations in the LKF models for the inpatient and outpatient area and in their documentation bases.

WHO update 2019 has been incorporated in the Austrian version of ICD-10 2020. Twenty-five new diagnosis codes were implemented, and six codes were deleted according to the LKF 2020 model.

The following six diagnosis codes were deleted:

  • B59 Pneumocystosis (J17.3*)
  • G56.4 Causalgia
  • K58.0 Irritable bowel syndrome with diarrhea
  • K58.9 Irritable bowel syndrome without diarrhea
  • M31.2 Lethal midline granuloma
  • R17 Jaundice, unspecified

The following twenty-five new diagnosis codes were introduced:

  • A92.5 Zika virus disease
  • B18.00 Chronic viral hepatitis B with delta virus: immune tolerance phase
  • B18.09 Chronic viral hepatitis B with delta virus: other and unspecified phase
  • B18.10 Chronic viral hepatitis B without delta virus: immune tolerance phase
  • B18.19 Chronic viral hepatitis B without delta virus: other and unspecified phase
  • B48.5 Pneumocystosis (J17.2 *)
  • G83.6 Central facial paresis
  • G90.5 Complex regional pain syndrome, type I
  • G90.6 Complex regional pain syndrome, type II
  • G90.7 Complex regional pain syndrome, other and unspecified type
  • G94.3 Encephalopathy in other diseases classified elsewhere
  • J98.7 Respiratory tract infection, not elsewhere classified
  • K55.3 Small intestine angiodysplasia
  • K58.1 Irritable bowel syndrome, predominant diarrhea [RDS-D]
  • K58.2 Irritable bowel syndrome, constipation-dominant [RDS-O]
  • K58.3 Irritable bowel syndrome with changing (mixed) stool habits [RDS-M]
  • K58.8 Other and unspecified irritable bowel syndrome
  • K66.2 Retroperitoneal fibrosis
  • M75.6 Labral lesion with a degenerative change in shoulder joint
  • P35.4 Congenital Zika virus disease
  • R00.3 Pulseless electrical activity not elsewhere classified graces
  • R17.0 Hyperbilirubinemia with jaundice, not elsewhere classified
  • R17.9 Hyperbilirubinemia without jaundice, not elsewhere classified
  • T76 Unspecified damage due to external causes
  • Z22.7 # Latent tuberculosis

New codes were introduced to code the gestational age in childbirth from 21 to 42 completed weeks (301.21 - 301.42). The new codes enable the recording of the frequency of deliveries in the obstetric facilities. These codes are mandatory as an additional diagnosis for stays with childbirth, but cannot be documented as the main diagnosis.

See the full details here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more